Glenmark Therapeutics Inc., USA launches Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC)
365Telugu.com online news,Mahwah, New Jersey, August 20, 2024: Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce it has launched1
Sun. Dec 22nd, 2024
